# Study of SGR-3515 In Participants With Advanced Solid Tumors.

Source: https://onco.cc/trials/nct06463340/  
OnCo record `nct06463340` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of SGR-3515 run by Schrödinger, Inc., now recruiting.

## Summary

Study of SGR-3515 In Participants With Advanced Solid Tumors. is a phase 1 interventional study registered as NCT06463340 by Schrödinger, Inc., with 52 participants planned, started 2024-06-18. Conditions recorded: Advanced Solid Tumor. Interventions recorded: SGR-3515.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06463340
- Phase: 1
- Setting: A First-In-Human, Phase 1, Dose Escalation Study of SGR-3515 In Participants With Advanced Solid Tumors.
- Sponsor: Schrödinger, Inc.
- Enrolled: 52

## Sources

- ClinicalTrials.gov NCT06463340: https://clinicaltrials.gov/study/NCT06463340

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [SGR-3515](https://onco.cc/drugs/sgr-3515/)
- companies: [Schrödinger](https://onco.cc/companies/schrodinger/)

---
JSON: https://onco.cc/api/v1/entities/nct06463340.json